CIK 0000943819 · Large accelerated filer
RESMED INC
Sign in to watch- Tickers
- RMD RSMDF
- Exchange
- NYSE, OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980152841
- Phone
- 8587462400
- Business address
- 9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA, 92123
Securities
- RMD ResMed Inc. Common Stock NYSE
- RSMDF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,744,605
- in 5 filings, $3.7M under 10b5-1 plans
Net −$3,744,605. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-12 | FARRELL PETER C Director | Sale 10b5-1 | −2,000 | $252.05 | $504K | 66,110 |
| 2025-11-11 | Gill Harjit Director | Shares withheld for taxes | −38.21 | $250.10 | $10K | 9,867 |
| 2025-11-11 | FARRELL PETER C Director | Shares withheld for taxes 10b5-1 | −162.95 | $250.10 | $41K | 68,110 |
| 2025-11-11 | Farrell Michael J. Chairman and CEO | Shares withheld for taxes | −2,231.55 | $250.10 | $558K | 465,634 |
| 2025-11-11 | Farrell Michael J. Chairman and CEO | Shares withheld for taxes | −3,459.33 | $250.10 | $865K | 462,175 |
| 2025-11-11 | Farrell Michael J. Chairman and CEO | Shares withheld for taxes | −2,205.7 | $250.10 | $552K | 459,969 |
| 2025-11-11 | De Witte Jan Director | Sale 10b5-1 | −487 | $250.25 | $122K | 5,319 |
| 2025-11-11 | De Witte Jan Director | Shares withheld for taxes 10b5-1 | −76.45 | $250.10 | $19K | 5,242 |
| 2025-11-11 | Rider Michael J Global General Counsel | Shares withheld for taxes | −135.08 | $250.10 | $34K | 11,231 |
| 2025-11-11 | Rider Michael J Global General Counsel | Shares withheld for taxes | −173.73 | $250.10 | $43K | 11,057 |
| 2025-11-11 | Rider Michael J Global General Counsel | Shares withheld for taxes | −715.49 | $250.10 | $179K | 10,342 |
| 2025-11-11 | Rider Michael J Global General Counsel | Shares withheld for taxes | −500.74 | $250.10 | $125K | 9,841 |
| 2025-11-07 | Farrell Michael J. Chairman and CEO | Option exercise 10b5-1 | +983 | $101.64 | $100K | 468,849 |
| 2025-11-07 | Farrell Michael J. Chairman and CEO | Option exercise 10b5-1 | +7,028 | $101.64 | $714K | 475,877 |
| 2025-11-07 | Farrell Michael J. Chairman and CEO | Sale 10b5-1 | −8,011 | $249.75 | $2.0M | 467,866 |
| 2025-11-07 | Farrell Michael J. Chairman and CEO | Option exercise · ResMed Common Stock Options 10b5-1 | −983 | 7,028 | ||
| 2025-11-07 | Farrell Michael J. Chairman and CEO | Option exercise · ResMed Common Stock Options 10b5-1 | −7,028 | 0 | ||
| 2025-11-03 | Sandercock Brett Chief Financial Officer | Option exercise 10b5-1 | +2,000 | $101.64 | $203K | 88,745 |
| 2025-11-03 | Sandercock Brett Chief Financial Officer | Sale 10b5-1 | −3,000 | $247.54 | $743K | 85,745 |
| 2025-11-03 | Sandercock Brett Chief Financial Officer | Option exercise · ResMed Common Stock Options 10b5-1 | −2,000 | 0 |
Page 5 of 18 · 355 trades